Skip to main content
Signal8

Chan Gerald

SEC insider (Form 3/4/5 filer). CIK 0001636579. Director at Apellis Pharmaceuticals, Inc. (APLS). 8 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.

Companies Chan Gerald has filed insider reports for

  • Apellis Pharmaceuticals, Inc. (APLS): Director
Chan Gerald profile photo

Chan Gerald

CIK: 0001636579

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Apellis Pharmaceuticals, Inc. logo
APLS

Apellis Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    May 14, 2026
    Tender Offer
    Direct
    25.7K shares-
  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    May 14, 2026
    Disposition
    Direct
    3.1K shares-
  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    May 14, 2026
    Disposition
    Direct
    5.7K shares-
  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    May 14, 2026
    Disposition
    Direct
    8K shares-
  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    May 14, 2026
    Disposition
    Direct
    3.9K shares-
  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    May 14, 2026
    Disposition
    Direct
    3.5K shares-
  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    Jan 1, 2026
    Award
    Direct
    8K shares-
  • Apellis Pharmaceuticals, Inc. logo
    APLS

    Apellis Pharmaceuticals, Inc.

    Jan 1, 2025
    Award
    Direct
    6.3K shares-

1-8 of 8